PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma : vimarsana.com

The combination induced responses in all 34 patients with advanced extranodal NK/T-cell lymphoma

Related Keywords

Massachusetts , United States , Beijing , China , Guangzhou , Guangdong , Peking , Long Zhong , Zhejiang , Chinese , America , Mike Bassett , Xiong Li , Shu Nan Qi , Sun Yat Sen University Cancer Center , Union Medical College , National Comprehensive Cancer Network , Chinese Academy Of Medical Sciences , Wen Long Zhong , South America , Chinese Academy , Medical Sciences , Peking Union Medical College , Tianx P ,